Fenerbahçe Mah. Operatör Cemil Topuzlu Cad. No:25/A, Kadıköy / İstanbul 0216 566 69 36 info@albio-allerji.com
ALBİO Allerji Ürünleri İthalat A.Ş.

Literatür

Bilimsel Yayınlar

Temsil ettiğimiz ürünlerin etkinliğini ve güvenilirliğini destekleyen klinik çalışmalar.

SmartPractice — TRUE Test®

TRUE Test® yama testi sisteminin standardizasyonu ve klinik kullanımına ilişkin yayınlar.

Standardizasyon

  1. Lehmann S V et al. “Characterization and chemistry of imidazolidinyl urea and diazolidinyl urea”. Contact Dermatitis 2006; 54: 50-58.
  2. Mortz C G et al. “Contact Allergy and Allergic Contact Dermatitis in Adolescents: Prevalence Measures and Associations”. Acta Derm Venereol 2002; 82: 352-58.
  3. Nielsen N H et al. “The association between contact allergy and hand eczema in 2 cross-sectional surveys 8 years apart”. Contact Dermatitis 2002; 46: 71-77.
  4. Brasch J et al. “Patch Testing of Nickel Sulfate and Potassium Dichromate with a Standardized Ready-to-use Test System Gives Highly Reproducible Results: A double-blind Multicentre Study”. Acta Derm Venereol 2001; 81: 122-24.
  5. Fowler J F, Finley B. “Quantity of Allergen Per Unit Area Is More Important Than Concentration for Effective Patch Testing”. Am J Contact Dermatitis 1995; 6: 157-59.
  6. Andersen K E et al. “Dose-response testing with nickel sulphate using the TRUE test® in nickel-sensitive individuals”. Br J Dermatol 1993; 129: 50-56.
  7. Tanglertsampan C, Maibach H I. “The role of vehicles in diagnostic patch testing”. Contact Dermatitis 1993; 29: 169-74.
  8. Fischer T et al. “The Science of Patch Test Standardization”. Immunology and Allergy Clinics of North America. W. B. Saunders 1989; 9: 417-33.
  9. Kreilgård B, Hansen J, Fischer T. “Chemical, pharmaceutical and clinical standardization of the TRUE Test™ caine mix”. Contact Dermatitis 1989; 21: 23-27.
  10. Kreilgård B, Hansen J. “Aspects of pharmaceutical and chemical standardization of patch test materials”. J Am Acad Dermatol 1989; 21: 836-38.
  11. Fischer T I, Maibach H I. “The thin layer rapid use epicutaneous test (TRUE-test), a new patch test method with high accuracy”. Br J Dermatol 1985; 112: 63-68.

Klinik çalışmalar

  1. Bruynzeel D P et al. “Monitoring the European Standard Series in 10 centres 1996-2000”. Contact Dermatitis 2005; 53: 146-52.
  2. Jensen C D, Andersen K E. “Course of contact allergy in consecutive eczema patients patch tested with TRUE Test™ panels 1 and 2 at least twice over a 12-year period”. Contact Dermatitis 2005; 52: 242-46.
  3. Agner T et al. “Standardization of the TRUE Test imidazolidinyl urea and diazolidinyl urea patches”. Contact Dermatitis 2001; 45: 21-25.
  4. Fischer T et al. “Clinical standardization of the TRUE Test™ formaldehyde patch”. Curr Probl Dermatol. Basel, Karger 1995; 22: 24-30.
  5. Wilkinson J D et al. “European multicenter study of TRUE Test™, Panel 2”. Contact Dermatitis 1990; 22: 218-25.
  6. Stenberg B et al. “Swedish Multicenter Study with TRUE Test, Panel 2”. Current Topics in Contact Dermatitis. Springer-Verlag 1989: 518-19.
  7. Gollhausen R, Przybilla B, Ring J. “Reproducibility of patch test results: Comparison of TRUE Test and Finn Chamber test”. Current Topics in Contact Dermatitis. Springer-Verlag 1989: 524-29.
  8. Ruhnek-Forsbeck M et al. “Comparative Multi-center study with TRUE Test™ and Finn Chamber® Patch test Methods in Eight Swedish Hospitals”. Acta Derm Venereol 1988; 68: 123-28.
  9. Lachapelle J-M et al. “European multicenter study of the TRUE Test™”. Contact Dermatitis 1988; 19: 91-97.

Genel yama testi

  1. Militello G et al. “The Utility of the TRUE Test in a Private Practice Setting”. Dermatitis 2006; 17: 77-84.
  2. Bruze M et al. “Recommendation to include methyldibromo glutaronitrile in the European standard patch test series”. Contact Dermatitis 2005; 52: 24-28.
  3. Hoeck U. “More T.R.U.E. Test allergens are needed”. J Am Acad Dermatol 2005; 52: 538.
  4. Pratt M D et al. “North American Contact Dermatitis Group Patch-Test Results, 2001-2002 Study Period”. Dermatitis 2004; 15: 176-83.
  5. Warshaw E M, Moore J B, Nelson D. “Patch-Testing Practices of American Contact Dermatitis Society Members: A cross-sectional survey”. Am J Contact Dermatitis 2003; 14: 5-11.
  6. Saripalli Y V, Achen F, Belsito D V. “The detection of clinically relevant contact allergens using a standard tray of twenty-three allergens”. J Am Acad Dermatol 2003; 49: 65-69.
  7. Brod B et al. “To patch test or not to patch test: What is your threshold for patch testing?” Am J Contact Dermatitis 1999; 10: 94-97.
  8. Prue C et al. “Postmarketing survey results of T.R.U.E. Test, a new allergen patch test”. Am J Contact Dermatitis 1998; 9: 6-10.
  9. Rietschel R L. “Is Patch-Testing Cost-Effective?” J Am Acad Dermatol 1989; 21: 885-87.

Derleme makaleler

  1. Uter W et al. “Clinical update on contact allergy”. Curr Opin Allergy Clin Immunol 2005; 5: 429-36.
  2. Krob H A et al. “Prevalence and relevance of contact dermatitis allergens: A meta-analysis of 15 years of published T.R.U.E. Test data”. J Am Acad Dermatol 2004; 51: 349-53.
  3. Belsito D V. “Patch testing with a standard allergen (‘screening’) tray: rewards and risks”. Dermatol Ther 2004; 17: 231-39.
  4. Fischer T, Kreilgård B, Maibach H. “The True Value of the TRUE Test for Allergic Contact Dermatitis”. Curr Allergy Asthma Rep 2001; 1: 316-22.

Chemotechnique

Alüminyum duyarlılığı ve yama testi uygulamalarına ilişkin referans yayınlar.

  1. Tosti A, Vincenzi C, Peluso A M. Accidental diagnosis of aluminum sensitivity with Finn Chambers. Contact Dermatitis 1990; 23: 48-49.
  2. Cosnes A, Flechet M-L, Revuz J. Inflammatory nodular reactions after hepatitis B vaccinations due to aluminium sensitization. Contact Dermatitis 1990; 23: 65-67.
  3. Kaaber K, Nielsen A O, Veien N K. Vaccination granulomas and aluminum allergy: course and prognostic factors. Contact Dermatitis 1992; 26: 304-306.
  4. Nielsen A O, Kaaber K, Veien N K. Aluminum allergy caused by DTP vaccine. Ugeskr Laeger 1992; 154(27): 1900-1.
  5. Veien N K, Hattel T, Laurberg G. Systemically aggravated contact dermatitis caused by aluminum in toothpaste. Contact Dermatitis 1993; 28: 199-200.
  6. Dwyer C M, Kerr R E. Contact allergy to aluminum in 2 brothers. Contact Dermatitis 1993; 29: 36-38.
  7. Lopez S et al. Aluminium allergy in patients hyposensitized with aluminium-precipitated antigen extracts. Contact Dermatitis 1994; 31(1): 37-40.
  8. Barbaud A, Schmutz J L, Mougeolle J M. Cutaneous immunoallergic reactions caused by vaccines. Ann Dermatol Venereol 1995; 122(3): 129-38.
  9. Veien N K. Routine patch testing with AlCl3. Contact Dermatitis 1996; 35(2): 126.
  10. Helgesen A L, Austad J. Contact urticaria from aluminium and nickel in the same patient. Contact Dermatitis 1997; 37(6): 303-4.
  11. Bajaj A K et al. Aluminium contact sensitivity. Contact Dermatitis 1997; 37(6): 307-8.
  12. Skowron F et al. Persistent nodules at sites of hepatitis B vaccination due to aluminium sensitization. Contact Dermatitis 1998; 39(3): 135-6.
  13. Peters T et al. Occupational contact sensitivity to aluminium in a machine construction plant worker. Contact Dermatitis 1998; 39(6): 322-3.
  14. Purello-D'Ambrosio F et al. Aluminium allergy in a patient with occupational contact dermatitis. Allergol Immunopathol (Madr) 2000; 28(2): 74-5.
  15. Kubo Y, Nonaka S, Yoshida H. False positive reaction to patch testing with aqueous mercuric chloride in an aluminum Finn Chamber. Contact Dermatitis 1992; 26: 136-137.
  16. Bruze M, Björkner B, Lepoittevin J-P. Occupational allergic contact dermatitis from ethylcyanoacrylate. Contact Dermatitis 1995; 32: 156-159.
  17. Kubo Y et al. Does patch testing with ammoniated mercury in a Finn Chamber give a false positive reaction? Contact Dermatitis 1992; 27: 118-119.
  18. Fischer T. Design considerations for patch testing. American Journal of Contact Dermatitis 1994; 5: 70-75.
  19. Guin J (ed). Practical Contact Dermatitis. Niklasson B. Chapter 51, Appendix A. McGraw-Hill 1995.
  20. Kanerva L, Elsner P, Wahlberg J E, Maibach H I (eds). Handbook of Occupational Dermatology. Niklasson B. Chapter 184. Springer-Verlag 2000.

Alpretec — MicroAir Pristine®

Akar geçirmez kılıfların etkinliği ve erken dönem akar alerjeni maruziyeti üzerine çalışmalar.

  1. Mahakittikun V et al. Mite penetration of different types of material claimed as mite proof by the Siriraj chamber method. J Allergy Clin Immunol 2006; 118(5): 1164-8. — 9 ülkeden 32 akar geçirmez kılıfın karşılaştırması.
  2. Miller J D et al. Nonwoven in contrast to woven mattress encasings accumulate mite and cat allergen. J Allergy Clin Immunol 2007; 120(4): 977-979.
  3. IBT Laboratories. Pristine® kumaşının yatak ve yastıklarda bulunan akar alerjenlerinin %99'undan fazlasını bloke ettiğini gösteren laboratuvar testi.
  4. Mahmic A, Tovey E R, Molloy C A, Young L. House dust mite allergen exposure in infancy. Clin Exp Allergy 1998; 28(12): 1487-92.
  5. Schönberger H J et al. Prenatal exposure to mite and pet allergens and total serum IgE at birth in high-risk children. Pediatr Allergy Immunol 2005; 16(1): 27-31.

DermaSilk®

DermaSilk® terapötik giysilerle yapılmış klinik çalışmalar DermaSilk Türkiye sitesinde yer almaktadır.

Klinik çalışmaları görüntüle